期刊文献+

职业性接触抗肿瘤药物甲氨喋呤工人的遗传损伤 被引量:7

Investigating genetic damage of workers occupationally exposed to methotrexate
原文传递
导出
摘要 目的用3个遗传终点来研究接触甲氨喋呤(MTX)工人的遗传损伤。方法外周血分别来自21名生产MTX工人和21名对照组工人。用微核试验、彗星试验、hprt基因突变试验和TCR基因突变试验对两组人群进行检测。结果工人组平均微核率(MNR)、平均微核细胞率(MCR)分别为10.10‰±0.95‰和8.05‰±0.75‰,明显高于对照组(5.48‰±0.82‰和4.38‰±0.58‰),差异有统计学意义(P<0.01)。工人组和对照组的平均尾长(MTL)分别为(1.30±0.06)、(0.07±0.01)μm,差异有统计学意义(P<0.01)。但两组平均尾相(MTM)的差异无统计学意义(P>0.05)。工人组的hprt和TCR平均突变率分别为1.00‰±0.02‰和(6.87±0.52)×10-4,明显高于对照组[0.86‰±0.01‰和(1.67±0.14)×10-4],差异有统计学意义(P<0.01)。结论生产MTX工人某种程度上存在遗传损伤。 Objective To study genetic damage of workers alone occupationally exposed to methotrexate (MTX) with three end-points. Methods The blood samples from 21 workers exposed to MTX and 21 controls were detected with micronueleus test, comet assay, hprt gene mutation test and TCR gene mutation test. Results Themean mieronuclei rate(MNR) and mean mieronueleated cells rate(MCR) in 21 workers were 10.10‰ ± 0.95‰ and 8.05‰ ± 0. 75‰ , respectively, which were significantly higher than those (5.48‰ ± 0.82‰ and 4.38‰ ±0.58 ‰ ) in eontrol(P 〈 0.01) .The mean tail length(MTL) of 21 workers and 21 controls were ( 1.30 ± 0.06) μm and (0.07 ± 0.01 ) μm, respectively, there was significant difference between workers and controls (P 〈 0.01 ). But the difference between workers and controls for mean tail moment(MTM) was not signifieant(P 〉 0.05).The average mutation frequeney(Mf-hprt) of hprt and (Mf-TCR) of TCR in workers were 1.00‰ ± 0.02‰ and (6.87 ± 0.52) × 10^-4,respectively,which were significantly higher than thoseE0.86‰ ± 0.01‰ and (1.67 ± 0.14) × 10^-4] in eontrol(P 〈 0.01). Conclusion The genetic damage to some extent appeared in workers occupationally exposed to methotrexate.
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2005年第6期411-413,共3页 Chinese Journal of Industrial Hygiene and Occupational Diseases
基金 浙江省卫生厅科研基金项目(2003B029)
关键词 抗肿瘤药 职业暴露 变异(遗传学) Antineoplastic agents Occupational exposure Variation(genetics)
  • 相关文献

参考文献10

  • 1Sorsa M, Anderson D. Monitoring of occupational exposure to cytostatic anticancer agents. Murat Res, 1996,355: 253-261.
  • 2Shahin AA, Ismail MM, Saleh AM, et al. Protective effect of folinic acid on low-dose methotrexate genotoxicity. Z Rheumatol, 2001,60: 63-68.
  • 3Kasahara Y, Nakai Y, Miura D, et al. Mechanism of induction of micronuclei and chromosome aberrations in mouse bone marrow by nultiple treatments of methotrexate. Mutat Res, 1992,280:117-128.
  • 4Keshava C, Keshava N, Whong WZ, et al. Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells. Mutat Res,1998,397: 221-228.
  • 5Kopjar N, Garaj-Vrhovac V. Application of the alkaline comet assay in human biomonitoring for genotoxicity: a study on Croatian medical personnel handling antineoplastic drugs. Mutagenesis, 2001,16: 71-78.
  • 6Fenech M, Morley AA. Measurement of micronuclei in lymphocytes. Mutat Res, 1985,147: 29-36.
  • 7Lou JL, He JL, Jin LF, et al. Measuring the genetic damage in cancer patients during radiotherapy with three genetic end-points. Mutagenesis,2004,19: 457-464.
  • 8Singh NP,McCoy MT,Tice RR,et al.A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res,1988,175:184-191.
  • 9Kyoizumi S, Kusunoki Y, Seyama T, et al. In vivo somatic mutations in Werner's syndrome. Hum Genet, 1998,103:405-410.
  • 10Kubota M, Lin YW, Hamahata K, et al. Cancer chemotherapy and somatic cell mutation. Mutat Res, 2000,470: 93-102.

同被引文献56

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部